Kewaunee Scientific Corporation carries a market capitalization of 103.30M, placing it among publicly traded companies globally. Its enterprise value stands at 128.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 103.30M |
| Enterprise Value | 128.26M |
Kewaunee Scientific Corporation currently has 2.87M shares outstanding.
| Shares Outstanding | 2.87M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Kewaunee Scientific Corporation trades at a trailing price-to-earnings ratio of 11.01. The price-to-sales ratio is 0.38, and the price-to-book ratio stands at 1.39.
| PE Ratio | 11.01 |
| PS Ratio | 0.38 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 2.21 |
| P/FCF Ratio | 5.92 |
| P/OCF Ratio | 5.69 |
On an enterprise value basis, Kewaunee Scientific Corporation trades at an EV/EBITDA multiple of 5.58 and an EV/FCF ratio of 5.94. The EV/Sales ratio of 0.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.67 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.45 |
| EV / EBITDA | 5.58 |
| EV / EBIT | 7.67 |
| EV / FCF | 5.94 |
Kewaunee Scientific Corporation maintains a current ratio of 2.18, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.30, indicating elevated leverage, while an interest coverage ratio of 5.95 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.18 |
| Quick Ratio | 1.42 |
| Debt / Equity | 39.30 |
| Debt / EBITDA | 1.31 |
| Interest Coverage | 5.95 |
Kewaunee Scientific Corporation posts a return on equity of 13.52 and a return on invested capital of 11.46.
| Return on Equity (ROE) | 13.52 |
| Return on Assets (ROA) | 5.16 |
| Return on Invested Capital (ROIC) | 11.46 |
| Return on Capital Employed (ROCE) | 10.35 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.36 |
Over the trailing twelve months, Kewaunee Scientific Corporation has paid 3.27M in income taxes, reflecting an effective tax rate of 23.80.
| Income Tax | 3.27M |
| Effective Tax Rate | 23.80 |
Kewaunee Scientific Corporation's stock has declined approximately -38.80014% over the past 52 weeks. The 50-day moving average sits at 37.53, while the 200-day moving average is 38.55.
| Beta (5Y) | N/A |
| 52-Week Price Change | -38.80014% |
| 50-Day Moving Average | 37.53 |
| 200-Day Moving Average | 38.55 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Kewaunee Scientific Corporation generated 282.00M in revenue and converted that into 9.62M in net income, yielding earnings per share of 3.51. EBITDA reached 23.00M, while operating income came in at 16.72M.
| Revenue | 282.00M |
| Gross Profit | 80.44M |
| Operating Income | 16.72M |
| Pretax Income | 13.73M |
| Net Income | 9.62M |
| EBITDA | 23.00M |
| EBIT | 16.72M |
| Earnings Per Share (EPS) | 3.51 |
Kewaunee Scientific Corporation holds 9.95M in cash and equivalents against 30.19M in total debt, resulting in a net debt position of 9.82M. Total book value stands at 75.96M, with working capital of 57.05M providing operational flexibility.
| Cash & Cash Equivalents | 9.95M |
| Total Debt | 30.19M |
| Net Debt | 9.82M |
| Equity (Book Value) | 75.96M |
| Book Value Per Share | 26.54 |
| Working Capital | 57.05M |
Kewaunee Scientific Corporation produced 18.63M in operating cash flow over the past twelve months.
| Operating Cash Flow | 18.63M |
| Capital Expenditures | N/A |
| Free Cash Flow | 18.63M |
| FCF Per Share | 6.51 |
Kewaunee Scientific Corporation operates with a gross margin of 28.52, reflecting its pricing power and cost economics. The operating margin of 5.93 and net profit margin of 3.41 provide insight into operational efficiency.
| Gross Margin | 28.52 |
| Operating Margin | 5.93 |
| Pretax Margin | 4.87 |
| Profit Margin | 3.41 |
| EBITDA Margin | 8.15 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 18.24 |
| FCF Yield | 16.88 |
Kewaunee Scientific Corporation's most recent stock split took place on January 7, 1985 with a 2:3 split ratio.
| Last Split Date | 1/7/1985 |
| Split Ratio | 2:3 |
Kewaunee Scientific Corporation posts an Altman Z-Score of 3.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.98 |